Patent Watch: Have the Biosimilar Floodgates Been Opened in the United States?

30 April 2015 Nature Reviews Publication
Authors: Courtenay C. Brinckerhoff Kristel Schorr

Nature Reviews

Partners Courtenay Brinckerhoff and Kristel Schorr contributed an article to Nature Reviews, “Patent Watch: Have the Biosimilar Floodgates Been Opened in the United States?” on April 30, 2015. The article discussed the first US Food and Drug Administration’s first approval of a biosimilar product and the regulatory hurdles products must clear before entering the US market.

Related Services

Insights

Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
U.S. Companies Must Prepare to Pay Higher Wages for Specialty Occupation Foreign Workers
30 November 2020
Labor & Employment Law Perspectives
A Shield for Employers: State COVID-19 Indemnity Laws
30 November 2020
Coronavirus Resource Center:Back to Business
Federal Circuit Clarifies The “Reasonably Pertintent” Analogous Art Standard
30 November 2020
PTAB Trial Insights
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar